7 May 2021
Latham & Watkins Advises Science 37 in US$1.05 billion de-SPAC transaction with LifeSci Acquisition II Corp.
Advising firms
Deal team
19 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Ryan Maierson Lead | Latham & Watkins LLP | Partner | M&A | Houston |
| Thomas Brandt Lead | Latham & Watkins LLP | Partner | M&A | Houston |
| Erika Weinberg Lead | Latham & Watkins LLP | Partner | capital markets | New York |
| Denny Lee | Latham & Watkins LLP | Associate | Not stated | Houston |
| Kate Wang | Latham & Watkins LLP | Associate | Not stated | Houston |
| Jacob Weiner | Latham & Watkins LLP | Associate | Not stated | Houston |
| Carlyle Reid | Latham & Watkins LLP | Associate | Not stated | Houston |
| Taylor Stevens | Latham & Watkins LLP | Associate | Not stated | New York |
| Pardis Zomorodi | Latham & Watkins LLP | Partner | tax | Century City |
| Abigail Friedman | Latham & Watkins LLP | Associate | tax | Los Angeles |
| Julie Crisp | Latham & Watkins LLP | Partner | benefits and compensation | Bay Area |
| Courtney Thomson | Latham & Watkins LLP | Associate | benefits and compensation | Washington, D.C. |
| Kieran Dickinson | Latham & Watkins LLP | Counsel | intellectual property | Washington, D.C. |
| Ryan Sanders | Latham & Watkins LLP | Associate | intellectual property | Bay Area |
| Ben Haas | Latham & Watkins LLP | Partner | healthcare and life sciences | Washington, D.C. |
| Lacey Henry | Latham & Watkins LLP | Associate | healthcare and life sciences | New York |
| Jennifer Archie | Latham & Watkins LLP | Partner | data privacy | Washington, D.C. |
| Jimmy Smith | Latham & Watkins LLP | Associate | data privacy | Washington, D.C. |
| Nathan Seltzer | Latham & Watkins LLP | Partner | compliance | London |
16 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 1.05bn (US$1.05 billion)
- What the figure measures
- Enterprise value
- Client
- Science 37, Inc.Target
- Counterparties
- LifeSci Acquisition II Corp. (Buy-side)